Outer membrane vesicle vaccines
Outer Membrane Vesicles (OMV) have received increased attention in recent years as a vaccine platform against bacterial pathogens. OMV from Neisseria meningitidis serogroup B have been extensively explored. Following the success of the MeNZB OMV vaccine in controlling an outbreak of N. meningitidis...
Glavni autori: | Micoli, F, MacLennan, CA |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
Elsevier
2020
|
Slični predmeti
-
Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1
od: Marini, A, i dr.
Izdano: (2017) -
Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella
od: Micoli, F, i dr.
Izdano: (2018) -
Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1.
od: Arianna Marini, i dr.
Izdano: (2017-01-01) -
Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines
od: Francesca Micoli, i dr.
Izdano: (2023-05-01) -
Outer Membrane Vesicles: An Emerging Vaccine Platform
od: Dharmendra Kashyap, i dr.
Izdano: (2022-09-01)